LOGIN TO YOUR ACCOUNT

Username
Password
Remember Me
Or use your Academic/Social account:

CREATE AN ACCOUNT

Or use your Academic/Social account:

Congratulations!

You have just completed your registration at OpenAire.

Before you can login to the site, you will need to activate your account. An e-mail will be sent to you with the proper instructions.

Important!

Please note that this site is currently undergoing Beta testing.
Any new content you create is not guaranteed to be present to the final version of the site upon release.

Thank you for your patience,
OpenAire Dev Team.

Close This Message

CREATE AN ACCOUNT

Name:
Username:
Password:
Verify Password:
E-mail:
Verify E-mail:
*All Fields Are Required.
Please Verify You Are Human:
fbtwitterlinkedinvimeoflicker grey 14rssslideshare1
Elliott, SP; Brandt, SD; Wallach, J; Morris, H; Kavanagh, PV
Publisher: OXFORD UNIV PRESS INC
Languages: English
Types: Article
Subjects: RS, RM
2-Methoxydiphenidine, i.e. 1-[1-(2-methoxyphenyl)-2-phenylethyl]piperidine, also known as 'MXP' or '2-MeO-diphenidine' (or 2-MXP), has been available as a 'research chemical' since 2013 as a purported alternative to the 'dissociative anesthetics' methoxetamine and ketamine. Three deaths which involved the detection of 2-MXP in post-mortem blood and urine were encountered in forensic casework. The 2-, 3- and 4-methoxyphenyl positional isomers were synthesized to confirm the identity and concentration of 2-MXP. The 2-MXP femoral blood concentrations in the cases were found to be 24.0, 2.0 and 1.36 mg/L (the latter with an alternative cause of death). Some additional prescription drugs were encountered at therapeutic concentrations in all three cases. Analysis of the biofluids allowed the detection and characterization of various metabolites, including the suggested presence of hydroxy-2-MXP as the main metabolite with the hydroxyl group located on the piperidine rather than the phenyl or benzyl moiety. Additional metabolites included O-desmethyl-2-MXP and hydroxylated O-desmethyl-2-MXP. Diphenidine and hydroxy-diphenidine, also showing the presence of the hydroxyl group on the piperidine ring, were also detected. It was not possible to identify whether these arose from 2-MXP biotransformation or whether they represented the presence of diphenidine as a separate substance. These are the first published fatalities involving 2-MXP and presents analytical data to assist analytical toxicologists with future casework.
  • The results below are discovered through our pilot algorithms. Let us know how we are doing!

    • 2. Domino, E.F., Kamenka, J.M., editors. Sigma and phencyclidine-like compounds as molecular probes in biology. Ann Arbor: NPP Books, 1988.
    • 3. Lodge, D., Danysz, W., Parsons, C.G., editors. Ionotropic glutamate receptors as therapeutic targets. Johnson City, TN: F.P Graham Publishing Co., 2002.
    • 4. Morris, H., FWallach, J. (2014) From PCP to MXE: a comprehensive review of the o non-medical use of dissociative drugs. Drug Testing and Analysis, 6, 614-632.
    • 5. Brandt, S.D., Kingr,L.A., Evans-Brown, M. (2014) The new drug phenomenon. Drug Testing and Analysis, 6, 587-597.
    • 12. Gray, N.M., Cheng, B.K. 1,2-Diarylethylamines for treatment of neurotoxic injury: G.D. Searle and Co., USA., 1989: 67 pp.
    • 13. Westphal, F., Junge, T., Jacobsen-Bauer, A., Rösner, P. (2010) LefetaminDerivate: alte Bekannte neu auf dem Drogenmarkt. Toxichem Krimtech, 77, 46-58.
    • 15. Tainter, M.L., Luduena, F.P., Lackey, R.W., Neuru, E.N. (1943) Actions of a series of diphenyl-ethylamines. Journal of Pharmacology and Experimental Therapeutics, 77, 317-323.
    • 16. Natsuka, FK., Nakamura, H., Uno, H., Umemoto, S. (1975) Studies on 1- substituted 4-(1,2-diphenylethyl)piperazine derivatives and their analgesic activities. Journal of MedicionalChemistry, 18, 1240-1244.
    • 17. Natsuka, K., Nakarmura, H., Negoro, T., Uno, H., Nishimura, H. (1978) Studies on 2. Structure-activity relaRtionships of 1-cycloalkyl-4-(1,2-diphenylethyl)piperazines. 1-substituted 4-(1,2-diphenylethyl)piperazine derivatives and their analgesic activities. Journal of Medicinal Chemistry, 21, 1265-1269.
    • e 19. Berger, M.L., Schweifer, A., Rebernik, wP., Hammerschmidt, F. (2009) NMDA receptor affinities of 1,2-diphenylethylamine and 1-(1,2-diphenylethyl)piperidine enantiomers and of related compounds. Bioorganic & Medicinal Chemistry, 17, 3456- 3462.
    • 22. Le Gall, E., Troupel, M., Nedelec, J.Y. (2006) One-step three-component coupling of aromatic organozinc reagents, secondary amines, and aromatic aldehydes into functionalized diarylmethylamines. Tetrahedron, 62, 9953-9965.
    • 23. Elliott, S., Smith, C. (2008) Investigation of the first deaths in the United Kingdom involving the detection and quantitation of the piperazines BZP and 3-TFMPP. Journal of Analytical Toxicology, 32, 172-177.
    • 24. Roth, B.L., Gibbons, S., Arunotayanun, W., Huang, X.P., Setola, V., Treble, R. et al. (2013) The ketamine analogue methoxetamine and 3- and 4-methoxy analogues of phencyclidine are high affinity and selective ligands for the glutamate NMDA receptor. PLoS One, 8, e59334.
    • e d t O e h e t e s a e l m l a i t n e d i f n o 296.20089 312.19581 282.18524 298.18016 266.19033 282.18524
  • No related research data.
  • Discovered through pilot similarity algorithms. Send us your feedback.

Share - Bookmark

Cite this article